Activation of Insulin-Like Growth Factor-2 Ameliorates Retinal Cell Damage and Exerts Protection in in vitro Model of Diabetic Retinopathy
Conclusion: The finding of the investigation, therefore, shows that the use of IGF2 activators may prevent the progression of ocular dysfunction in the control of diabetes-related complications.Neuroimmunomodulation
Source: Neuroimmunomodulation - Category: Allergy & Immunology Source Type: research
More News: Allergy & Immunology | Antidoxidants | Blindness | Brain | Diabetes | Endocrinology | Genetics | Insulin | Neurology | Opthalmology | Study | Vitamin A